学术探索
学术期刊
新闻热点
数据分析
智能评审

Plasma olanzapine and clinical response

被引：3
作者：
Chong, SA
Remington, G
机构：
[1] Clarke Inst Psychiat, Schizophrenia Div, Toronto, ON M5T 1R8, Canada
[2] Woodbridge Hosp & Inst Mental Hlth, Singapore, Singapore
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1999年 / 19卷 / 02期
关键词：
D O I：
10.1097/00004714-199904000-00023
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：192 / 193
页数：2
相关论文
共 8 条
[1]   Drug-metabolizing enzymes and therapeutic drug monitoring in psychiatry [J].
Brosen, K .
THERAPEUTIC DRUG MONITORING, 1996, 18 (04) :393-396
[2]   Olanzapine - A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses [J].
Fulton, B ;
Goa, KL .
DRUGS, 1997, 53 (02) :281-298
[3]  
HASEGAWA M, 1993, J CLIN PSYCHOPHARM, V13, P383
[4]  
HUGHES JR, 1986, AM J PSYCHIAT, V143, P993
[5]  
NEMEROFF CB, 1997, J CLIN PSYCHIAT MONO, V15, P24
[6]   Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients [J].
Perry, PJ ;
Sanger, T ;
Beasley, C .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (06) :472-477
[7]  
PERRY PJ, 1991, AM J PSYCHIAT, V148, P231
[8]  
Ring BJ, 1996, J PHARMACOL EXP THER, V276, P658
1